Signaling Pathways - Integrin-ligand interactions - Insulin-like growth factors (IGFs) - potassium channel - Reverse Transcriptases
清除全部
-
B3708 RGD (Arg-Gly-Asp) Peptides1 CitationTarget: Integrin-ligand interactionsSummary: 抑制整合素结合到RGD基序 -
B2224 Etravirine (TMC125)中文名: 依曲韦林Target: Reverse TranscriptasesSummary: 逆转录酶抑制剂 -
B2223 Zalcitabine中文名: 扎西他滨Target: Reverse TranscriptasesSummary: 逆转录酶抑制剂 -
A8620 AZD-34633 CitationTarget: ALK|Insulin-like growth factors (IGFs)Summary: ALK/IGF1R抑制剂 -
A8554 Dapivirine (TMC120)中文名: 达匹维林Target: Reverse TranscriptasesSummary: 非核苷逆转录酶抑制剂 -
A8422 Emtricitabine1 Citation中文名: 恩曲他滨Target: Reverse TranscriptasesSummary: 逆转录酶抑制剂 -
A8410 Didanosine中文名: 去羟肌苷Target: Reverse TranscriptasesSummary: 逆转录酶抑制剂 -
A1755 Tenofovir Disoproxil Fumarate中文名: 富马酸替诺福韦酯Target: Reverse TranscriptasesSummary: 抗逆转录制剂（HIV-1 RT 抑制剂） -
A3374 Dronedarone中文名: 决奈达隆Target: Cytochrome P450 (CYP450)|sodium channel|adrenergic receptor|potassium channel|calcium channelSummary: CYP3A4和2D6抑制剂